Profusa (NVACW) Common Equity (2021 - 2026)
Profusa posted quarterly Common Equity of -$28.2 million for Q1 2026, up 76.87% year-on-year from -$15.9 million in Q1 2025, and down 5.78% on a QoQ basis from -$26.7 million in Q4 2025.
Profusa (NVACW) has 6 years of Common Equity data on file, last reported at -$28.2 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity rose 76.87% year-over-year to -$28.2 million; the trailing twelve-month figure through Mar 2026 stood at -$28.2 million (up 76.87% YoY), and the FY2025 full-year result was -$26.7 million, up 77.64% from the prior year.
- Common Equity for Q1 2026 stood at -$28.2 million, down from -$26.7 million in the prior quarter.
- Across five years, Common Equity topped out at -$373856.0 in Q3 2022 and bottomed at -$124.2 million in Q2 2025.
- The 5-year median for Common Equity is -$28.2 million (2026), against an average of -$54.2 million.
- The widest annual swing landed in 2022, when Common Equity soared 89.52%; it then plunged 17656.3% in 2023.
- A 5-year view of Common Equity shows it stood at -$619476.0 in 2022, then slumped by 17656.3% to -$110.0 million in 2023, then fell by 8.37% to -$119.2 million in 2024, then surged by 77.64% to -$26.7 million in 2025, then fell by 5.78% to -$28.2 million in 2026.
- The last three Common Equity figures came in at -$28.2 million (Q1 2026), -$26.7 million (Q4 2025), and -$34.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 48.99 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.68 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Profusa | - | - | - | -28.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.20 Mn |
| Dec 31, 2025 | -26.66 Mn |
| Sep 30, 2025 | -33.96 Mn |
| Jun 30, 2025 | -124.18 Mn |
| Mar 31, 2025 | -121.92 Mn |
| Dec 31, 2024 | -119.21 Mn |
| Sep 30, 2024 | -116.96 Mn |
| Jun 30, 2024 | -114.47 Mn |
| Mar 31, 2024 | -112.06 Mn |
| Dec 31, 2023 | -110.00 Mn |
| Sep 30, 2023 | -3.48 Mn |
| Jun 30, 2023 | -2.87 Mn |
| Mar 31, 2023 | -3.31 Mn |
| Dec 31, 2022 | -619,476.00 |
| Sep 30, 2022 | -373,856.00 |
| Jun 30, 2022 | -1.12 Mn |
| Mar 31, 2022 | -2.20 Mn |
| Dec 31, 2021 | -5.91 Mn |